71 -11 (61) 2023 — Axmedova N.Sh., Tuxtayev D.A. — DISORDERS OF KIDNEY AND HEART FUNCTION A SPECIFIC ASPECT OF COMORBID PROGENY

DISORDERS OF KIDNEY AND HEART FUNCTION A SPECIFIC ASPECT OF COMORBID PROGENY

Axmedova N.Sh., Bukhara State Medical Institute named after Abu Ali ibn Sina

Tuxtayev D.A. Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume
Cardiorenal relationships are one of the pressing problems of today’s medicine. It is especially important
to determine the degree of primary injury of these two pathologies. This article presents the results of a
retrospective examination in which 4 types of cardiorenal syndrome are spread and factors that cause
comorbidity are analyzed for evaluation purposes.The results obtained showed that the frequency of
occurrence of Vascular Pathology in SBKS depends on the clinical level and age aspect of the disease.
Key words: Comorbidity, cardiorenal syndrome, chronic heart disease

First page

435

Last page

437

For citation: Axmedova N.Sh., Tuxtayev D.A. – DISORDERS OF KIDNEY AND HEART FUNCTION A SPECIFIC ASPECT OF COMORBID PROGENY //New Day in Medicine 2023 11(61): 435-437 https://newdaymedicine.com/index.php/2023/12/24/l-649/

LIST OF REFERENCES:

1. Boltayev K.J., Axmedova N.Sh. Xarakteristika fenomena razvitiya polidefitsitnыx sostoyaniy pri
   starenii //Problemы biologii i meditsinы. 2020;1:24-26.
2. Alyavi A.L., Kamilova U.K., Rasulova Z.D. Diagnostika i lecheniye xronicheskoy serdechnoy
   nedostatochnosti. // Monografiya. 2016;196.
3. Belyalov F.I. Lecheniye vnutrennix bolezney v usloviyax komorbidnosti. // Monogr. – 8-e izd.-
   Irkutsk : RIO IGIUVa, 2013;285.
4. Murkamilov I.T., Aytbayev K.A., Murkamilova J.A., Fomin V.V., Rayimjanov Z.R., Redjapova
   N.A., Yusupov F.A., Aydarov Z.A. Klinicheskoye znacheniye markyorov pochechnoy disfunktsii v
   stratifikatsii serdechno-sosudistogo riska. // Yevraziyskiy Kardiologicheskiy Jurnal. 2018;(4):64-78.
   https://doi.org/10.38109/2225-1685-2018-4-64-78
5. Tuxtayev D.A. Modern view on the problems of cardiorenal syndrome. // Art of Medicine.
   International Medical Scientific Journal 2.3 (2022).
6. Benetti E., Mastrocola R., Vitarelli G., et al. Empagliflozin Protects against Diet-Induced NLRP-3
   Inflammasome Activation and Lipid Accumulation. // J Pharmacol Exp Ther. 2016;359(1):45-53.
7. Cruz D.N., Schmidt-Ott K.M., Vescovo G., et al. Pathophysiology of cardiorenal syndrome type 2 in
   stable chronic heart failure: work group statements from the eleventh consensus conference of the
   Acute Dialysis Quality Initiative (ADQI). // Contrib Nephrol. 2013;182:117-136.
8. Herzog C.A., Asinger R.W., Berger A.K. et al. Cardiovascular disease in chronic kidney disease. A
   clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). // Kidney Int.
   2011;80:572-586.
9. Tkachenko Ye.I., Borovkova N.Yu., Buyanova M.V. Anemiya pri xronicheskoy serdechnoy
   nedostatochnosti: vzglyad na patogenez i puti korrektsii. // Kardiologiya Terapiya 2019;2(157), –
   DOI:10.31550/1727-2378-2019-157-2-31-36.